Aldo Pinchera
Overview
Explore the profile of Aldo Pinchera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
179
Citations
4600
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cetani F, Pardi E, Banti C, Borsari S, Ambrogini E, Vignali E, et al.
Expert Rev Endocrinol Metab
. 2019 Feb;
3(3):377-389.
PMID: 30754207
Parathyroid carcinoma is an uncommon cause of primary hyperparathyroidism (PHPT) and is usually associated with more severe clinical manifestations than its much more common benign counterpart, the parathyroid adenomas. The...
2.
Santini F, Giannetti M, Ricco I, Querci G, Saponati G, Bokor D, et al.
Endocr Pract
. 2014 Feb;
20(7):680-9.
PMID: 24518178
Objective: Sulfate conjugation of thyroid hormones is an alternate metabolic pathway that facilitates the biliary and urinary excretion of iodothyronines and enhances their deiodination rate, leading to the generation of...
3.
Fast S, Hegedus L, Pacini F, Pinchera A, Leung A, Vaisman M, et al.
Thyroid
. 2013 Dec;
24(4):727-35.
PMID: 24341527
Background: Enhanced reduction of multinodular goiter (MNG) can be achieved by stimulation with recombinant human thyrotropin (rhTSH) before radioiodine ((131)I) therapy. The objective was to compare the long-term efficacy and...
4.
Gamucci O, Lisi S, Scabia G, Marchi M, Piaggi P, Duranti E, et al.
Adipocyte
. 2013 May;
1(3):142-183.
PMID: 23700523
Haptoglobin (Hp) is an inflammatory and adiposity marker, its expression during obesity being specifically induced in the white adipose tissue (WAT). We previously reported that when challenged with a high...
5.
Tonacchera M, Dimida A, De Servi M, Frigeri M, Ferrarini E, De Marco G, et al.
J Clin Endocrinol Metab
. 2013 Mar;
98(4):E694-7.
PMID: 23482609
Background: Iodine deficiency is the result of insufficient intake of dietary iodine and as a consequence causes multiple adverse effects. About 2 billion individuals in the world are affected by...
6.
Di Bello V, Fabiani I, Conte L, Barletta V, Delle Donne M, Cuono C, et al.
Obesity (Silver Spring)
. 2013 Feb;
21(5):881-92.
PMID: 23404860
Objective: Obesity has reached global epidemic proportions and is associated with numerous comorbidities, including major cardiovascular (CV) diseases. Design And Methods: It has many adverse effects on hemodynamics and CV...
7.
Ciampi R, Mian C, Fugazzola L, Cosci B, Romei C, Barollo S, et al.
Thyroid
. 2012 Dec;
23(1):50-7.
PMID: 23240926
Background: Approximately 60% of sporadic medullary thyroid carcinomas (sMTC) remain orphan of a recognized genetic cause. Recently, a high percentage of RAS point mutations have been described in RET-negative sMTC....
8.
Ferrarini E, Russo L, Fruzzetti F, Agretti P, De Marco G, Dimida A, et al.
Maturitas
. 2012 Oct;
74(1):61-7.
PMID: 23107817
Objective: Premature ovarian insufficiency (POI) is defined as a primary ovarian defect characterized by absent menarche (primary amenorrhea) or premature depletion of ovarian follicles before the age of 40 (secondary...
9.
Profilo M, Sisti E, Marcocci C, Vitti P, Pinchera A, Nardi M, et al.
Thyroid
. 2012 Oct;
23(1):97-102.
PMID: 23088654
Background: Graves' orbitopathy (GO) is thought to be related to one or more autoantigens present in the thyroid and in orbital tissues. Although this may not imply a quantitative relation...
10.
Rocchi R, Lenzi R, Marino M, Latrofa F, Nardi M, Piaggi P, et al.
Thyroid
. 2012 Oct;
22(11):1170-5.
PMID: 23072549
Background: Patients with moderate to severe Graves' orbitopathy (GO) rather frequently require rehabilitative surgery after medical therapy. Diplopia is the most common side effect of orbital decompression (OD). The aim...